Notice ID: d9043102a4f545b08986a828adb3bebcCombined Synopsis/Solicitation
Brand Name or Equal: Ultra-Low-Field Portable MRI System
Archived on September 16, 2021. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:30 PM UTC−04:00
- Posted
- September 9, 2021
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 334510: Electromedical and Electrotherapeutic Apparatus Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Place of performance
- Bethesda, MD, 20892
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- NIH-NINDS-CSS-21-009467
- Notice ID
- d9043102a4f545b08986a828adb3bebc
Description
The National Institute for Neurological Disorders and Strokes (NINDS) has a requirement for an Ultra-Low-Field Portable MRI System that is brand name or equal to Hyperfine Researchs Swoop Portable MRI. The Equipment will provide NINDS investigators the ability to screen patients with multiple sclerosis on their bedside other than transferring them to the imaging facility. Please see Attachment 1 - Purchase Description for more information.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
NIH-NINDS-CSS-21-009467- Combined Synopsis
- Combined SynopsisCurrentSep 9, 2021
Brand Name or Equal: Ultra-Low-Field Portable MRI System
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This is a combined synopsis/solicitation for commercial products prepared in accordance with the Revolutionary Federal Acquisition Regulation (FAR) Overhaul (RFO) Parts 12 and 15. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 36C10X27R0005 is issued as a Request for Proposal (RFP) for NX EQ Ultrasonic Aspirator System: Tissue Ablation and related accessories. This acquisition is set-aside for Service Disabled Veteran Owned Small Business (SDVOSB) concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. Line Items: Refer to ATTACHMENT A PRICE COST SCHEDULE NX EQ Ultrasonic Aspirator System: Tissue Ablation for CLINs, quantities, and units of measure. Description of Requirements: Offerors shall provide descriptive literature which will be used to determine the extent to which it meets the salient characteristics listed in the Attachment B Product Description. All of the salient characteristics listed in the solicitation must be met to be considered eligible for award. Those proposals which fail to meet all of the salient characteristics will be rated Unacceptable and will be ineligible for award. Only new OEM equipment is acceptable. No refurbished, remanufactured, or gray market items will be considered. Delivery and Acceptance: Delivery is FOB Destination. Specific delivery locations and dates will be identified in individual orders issued under the contract. | - | Combined Synopsis | 12/01/2026 |
4 NOV 2026 - The purpose of this revision is to incorporate Revision 1 of the RPP, upload the Questions and Answers and to extend the offeror due date to 1600 EST, 20 November 2026. With the incorporation of this revision, final questions are due NLT 1600 EST, 9 November 2026. A follow on Questions and Answers for this period will be uploaded shortly after 9 November 2026. Three attachments will be uploaded in this RPP revision: 1) W91CRB-RPP-USHC_Rev 1 - changes are highlighted in red font to the following sections of the RPP: Sections 2.4, 5.1 & 5.2 2) W91CRB-RPP-USHC_QAs - .pdf containing 10 questions and answers 3) W91CRB-RPP-USHC_QAs_Cont. - Excel spreadsheet containing remaining questions ****************************************************************************************************************************************************** The Portfolio Acquisition Executive (PAE) Maneuver Ground Project Manager (PM) Maneuver Medical Devices (M2S) is issuing this Request for Prototype Proposals (RPP) to solicit solutions for an Ultrasound Diagnostic System, Hand Carried (USHC). The U.S. Army requires a Commercial-Off-The-Shelf (COTS) or Non-Developmental Item (NDI) hand-carried ultrasound device capable of supporting medical operations in austere Role of Care (ROC) 3 environments with little to no modification. The selected vendor(s) will deliver two (2) prototype units for operational and environmental testing (MIL-STD-810H). The solution must be FDA cleared for human use, Trade Agreements Act (TAA) compliant, and operate on standard CONUS/OCONUS power infrastructures. In accordance with 10 U.S.C. § 4022(f), the Government advises all offerors that a noncompetitive follow-on production contract or transaction may be awarded to the participant(s) of this Prototype Other Transaction Agreement (OTA) without the use of competitive procedures Submission Instructions: Proposals must be submitted via DoD SAFE file transfer or secure email. Submit to: Timothy Compton, Agreements Officer (timothy.j.compton7.civ@army.mil) Copy to: Roxanne A. Dalrymple, Agreements Specialist (roxanne.a.dalrymple.civ@army.mil) Please see attached. | - | Solicitation | 11/20/2026 |
The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), intends to award a contract to BIO-RAD on a sole-source basis pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, for the acquisition of QX700 E Droplet Digital PCR System, the Government intends to solicit and award a Purchase Order on a solesource basis because the Government's minimum technical requirements will be satisfied by BIO-RAD. DTM’s shared labs have ongoing experiments that require very precise assessment of sample quality and quantity. The QX700 E Droplet Digital PCR System delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. The QX700 E Droplet Digital PCR System* delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. BioRad Laboratories, Inc. is the original manufacturer and sole supplier of the QX700 E Droplet Digital PCR System. This piece of equipment utilizes Droplet Digital PCR for the absolute quantification of nucleic acids. This notice is not a request for competitive quotations. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required supplies and meet all specified technical and operational requirements. The Government will consider all timely capability statements received and determine whether the acquisition should proceed as a sole-source procurement or be competed. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement. Capability statements shall be submitted electronically to davisroshonna@mail.nih.gov no later than 9:00 a.m. EDT on November 18, 2026. Please reference Notice No. 75N98027Q00057 in the subject line of the response. | - | Combined Synopsis | 11/18/2026 |
Portfolio Acquisition Executive (PAE) Maneuver Ground Project Manager (PM) Maneuver Medical Devices (M2S) is issuing this Request for Prototype Proposals (RPP) under Other Transaction Authority (OTA) pursuant to 10 U.S.C. § 4022 to solicit prototype project proposals for a Scanner Ultrasonic Ocular device. The purpose of this RPP is to identify, select, and award two (2) prototype Other Transaction (OT) Agreement —for the delivery and demonstration of prototype scanner ultrasonic ocular devices that address the capability gap described herein. The awardee(s) shall deliver four (4) prototype devices for operational and environmental testing. The goal is to procure an FDA-approved commercial solution that requires minimal to no modifications to meet the technical specifications identified herein. | - | Combined Synopsis | 11/12/2026 |
This is a combined synopsis/solicitation for commercial products prepared in accordance with FAR part 12. This announcement constitutes the only solicitation. Proposals are being requested and a separate written solicitation will not be issued. Solicitation number 36C10X27R0004 is issued as a Request for Proposals (RFP) for Image-Guided Surgical Navigation Systems. This acquisition is set aside for Service-Disabled Veteran-Owned Small Businesses. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. Line Items: Refer to ATTACHMENT A - PRICE COST SCHEDULE_NX EQ Image-Guided Surgical Navigation System for CLINs, quantities, and units of measure. Description of Requirements: Offerors shall provide NX EQ Image-Guided Surgical Navigation Systems that meet the salient characteristics listed in ATTACHMENT B PRODUCT DESCRIPTION. Only new OEM equipment is acceptable. No refurbished, remanufactured, or gray market items will be considered. Delivery and Acceptance: Delivery is FOB Destination. Specific delivery locations and dates will be identified in individual orders issued under the contract. | - | Combined Synopsis | 11/05/2026 |
Additional Details
Solicitation Number
NIH-NINDS-CSS-21-009467
Archive Date
Sep 16, 2021
Office Address
Bethesda, MD, 20892